本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

534.49
+1.370.26%
盤後534.490.00000.00%19:30 EDT
成交量:18.76萬
成交額:1.01億
市值:123.23億
市盈率:-37.60
高:546.56
開:536.02
低:531.37
收:533.12
52周最高:615.00
52周最低:393.61
股本:2,305.55萬
流通股本:1,372.50萬
量比:0.91
換手率:1.37%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
淨資產收益率:-53.31%
總資產收益率:-17.84%
市淨率:23.53
市盈率(LYR):-41.59

資料載入中...

2022/08/04

重要事件披露

8-K - Current report
2022/06/17

重要事件披露

8-K - Current report
2022/05/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/09

重要事件披露

8-K - Current report
2022/05/09

重要事件披露

8-K - Current report
2022/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/24

重要事件披露

8-K - Current report
2022/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/04

重要事件披露

8-K - Current report
2021/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/05

重要事件披露

8-K - Current report
2021/07/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans